Tag: omicron variant

UPDATED: FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

Tina Marie (Ms. Cat)

FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

Related:

WSJ: FDA Eyes Second Covid-19 Booster Shot

A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.

I’m not buying the media’s scaremongering about the second omicron variant!

Various Coronavirus News Updates: U.S. National Emergency extended, Bill Gates disappointed, IVM, breakthrough cases, immunity + antibodies.

Tina Marie (Ms. Cat)

Biden to extend U.S. national emergency due to COVID-19 health risk

Bill Gates is Ready to Capitalize on ‘The Next Pandemic’

Estimated 73% of US now immune to omicron: Is that enough?

Arkansas county praises doctor who gave inmates ivermectin

2,044 Fully Vaccinated Indiana Residents Died Of COVID-19; 329,000 Breakthrough Cases Recorded

A test to determine COVID immunity could reshape US policy

I’m behind because I haven’t really been keeping up with coronavirus news. Out of sight, out of mind! 🤷🏼‍♀️

J&J pauses production of its Covid-19 vaccine despite persistent need 💰

Tina Marie (Ms. Cat)

J&J pauses production of its Covid-19 vaccine despite persistent need

The facility, in the Dutch city of Leiden, has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.

…

But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including omicron, when given as a two-shot regimen. As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.

…

Unlike companies such as Pfizer and Moderna, which have reaped billions of dollars in profits, Johnson & Johnson did not find the COVID vaccine to be a big moneymaker.

….

Since production of the COVID vaccine was halted late last year, the Netherlands plant has been manufacturing an experimental vaccine against respiratory syncytial virus, or RSV, that will be used for a clinical trial in older adults in wealthy countries, a person familiar with the matter said. Even if it proves effective, the vaccine is not expected to become available for several years.

Omicron pioneer Dr Angelique Coetzee pressured by world powers to exaggerate its seriousness

Tina Marie (Ms. Cat)

Omicron pioneer Dr Angelique Coetzee pressured by world powers to exaggerate its seriousness

“But I have stated many times before it can be a serious illness if you are unvaccinated and have comorbidities but for the majority of people it is a mild illness. I am the one who has seen the patients first-hand but the politicians won’t listen.”

Related:

Video source: The Jimmy Dore Show on YouTube